Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) shares were up 2.2% during trading on Monday . The company traded as high as $8.40 and last traded at $8.34. Approximately 1,025,258 shares traded hands during mid-day trading, an increase of 86% from the average daily volume of 551,962 shares. The stock had previously closed at $8.16.
Cybin Price Performance
The company’s 50-day simple moving average is $6.53 and its 200-day simple moving average is $6.88. The stock has a market capitalization of $1.27 billion and a P/E ratio of -61.21.
Cybin Company Profile
Cybin Inc (OTCMKTS: CLXPF) is a biotechnology company focused on the research, development and commercialization of psychedelic-based therapeutics for the treatment of mental health and wellness disorders. The company leverages proprietary drug discovery platforms to design novel analogues of psilocybin and other psychoactive compounds. Its programs aim to improve the safety, bioavailability and manufacturability of these molecules while addressing conditions such as depression, anxiety and substance use disorders.
Cybin’s pipeline encompasses several clinical and preclinical stage candidates.
Recommended Stories
- Five stocks we like better than Cybin
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
